6505--PLUVICTO-Novartis
Closed Special Notice Posted
- Solicitation number
- 36C24125Q0671
- Agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Health Administration Veterans Integrated Service Network 1, through its Networking Contracting Office located in West Haven, Connecticut, has issued a Special Notice for a sole source procurement of PLUVICTO radiopharmaceuticals. The VA intends to contract with Novartis Pharmaceuticals Corporation for Lu-177 vipivotide tetraxetan, a specialized radioligand therapeutic agent used to treat adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer. This procurement is being conducted under FAR 6.302-1 sole source authority, as Novartis is identified as the only FDA-approved manufacturer of this highly specialized therapeutic radiopharmaceutical. The contract will support the VA Connecticut Healthcare System located at 950 Campbell Ave, West Haven, Connecticut. The requirement involves 12 doses of PLUVICTO for treating 2 patients, with radiopharmaceutical preparation and delivery services to be performed at the contractor's facility by board-certified radiopharmacists.
The purpose of this Special Notice is to inform potential contractors of the VA's intent to proceed with sole source procurement while providing an opportunity for other parties to demonstrate their capability to provide the same services competitively. Interested parties must submit written responses clearly identifying their capability to satisfy the requirement by July 28, 2025, at 12:00 PM EST to Jerry Choinski at Jerry.Choinski@va.gov. The contract period of performance will run from August 1, 2025, to July 31, 2026, with deliveries required Monday through Friday between 7:00 AM and 3:00 PM. Contractors must be licensed by the Nuclear Regulatory Commission, regularly established in the radiopharmaceutical business, and provide bonded delivery personnel along with copies of licenses and certifications. The VA retains sole discretion in determining whether to open this requirement to competition based on responses received, and this notice does not constitute a solicitation or request for proposal.
Notice text
The Department of Veterans Affairs, Networking Contracting Office (NCO 01) located in West Haven, CT, intends to enter into a sole source procurement, pursuant to the authority of FAR 6.302-1, with Novartis Pharmaceuticals Corporation for the following requirement:
STATEMENT OF WORK RADIOPHARMACEUTICALS
Lu-177 vipivotide tetraxetan (PLUVICTO) is a radioligand therapeutic agent to perform the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive and metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitor (ARPI) therapy and are considered appropriate to delay taxane-based chemotherapy or have received prior taxane-based chemotherapy.
Radiopharmaceutical preparation and delivery of Lu-177 vipivotide tetraxetan (PLUVICTO) doses performed at contractor facility provided by a board-certified radiopharmacist and delivered to the Nuclear Medicine Service at VA Connecticut Healthcare located at 950 Campbell Ave., West Haven, CT, building one, ground floor. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Personnel assigned by the contractor to perform services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia.
A total of 12 doses of Pluvicto for 2 patients to treat prostate-specific membrane antigen (PSMA)-Positive.
Contractor s employees will deliver to the PET/CT Service and give deliveries directly to the PET Technologist on duty. Delivery personnel will be bonded by the contractor.
The contractor will provide for the placement of one or more telephone delivery order (s) per day for items listed in the Pricing and Cost Schedule, 24 hours per day, seven days a week, including holidays.
Contractor must be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals. The offeror must provide copies of licenses and certifications along with a quote to the Contracting Officer.
DELIVERY ORDERS:
Due to the demands of the Medical Center care requirements, there shall be no restriction to the number of orders which may be placed by VA, nor the number of deliveries required per day. In the event that the requirements may be determined in advance, a longer delivery time will be scheduled accordingly.
The delivery order shall specify contract item (s) and quantity, time (s) of delivery and applicable VA order number.
Orders can be placed orally by telephone and/or online.
DELIVERY LOCATION:
VA Connecticut Healthcare System. 950 Campbell Ave. West Haven, CT 06516. PET Center and/or Mobile PET Unit; building one.
Deliveries will be made Monday-Friday (excluding holidays which are listed below) between the hours of 7:00 AM and 3:00 PM.
Federal Holidays are as follows and include any other days specifically declared by the President of the United States to be deemed a holiday.
New Year s Day
Juneteenth
Thanksgiving
Martin Luther King s Birthday
Independence Day
Veterans Day
Presidents Day
Columbus Day
Christmas
Memorial Day
Labor Day
Access to the VAMC location during non-business hours shall be obtained by contacting the AOD located in the Emergency Department who will contact VA Police to accompany the delivery Person to the PET Center and supervise the delivery.
Deliveries will be supervised by the COR or their designee before beginning delivery operations. The contractor will contact the COR prior to delivery to arrange for delivery supervision.
DELIVERY COMMITMENT:
Time of delivery specified or mutually agreed to at the time of receipt of telephone order shall become mandatory upon the Contractor. Failure to perform in accordance with the delivery commitment may be grounds for termination of contract in accordance with the provisions for default.
PERIOD OF PERFORMANCE:
The contract will have a Period of Performance from 8/1/2025 to 7/31/2026.
SUPPLIES OR SERVICES AND PRICES/COSTS:
Contractor to provide Radiopharmaceutical product, PLUVICTO, as requested by authorized VA Staff, to support the West Haven campus of VA Connecticut Healthcare System (VACHS), 950 Campbell Ave, West Haven, CT 06516.
PERSON AUTHORIZED TO PLACE ORDERS:
In addition to the Contracting Officer, the COR is authorized to place orders under this contract, as well as any Certified Nuclear Medicine Technologist employed by the West Haven VA Hospital.
NOTIFICATION:
The services specified herein may be changed by written modification. The modification will be prepared by the VA Contracting Officer.
The NAICS code for this requirement is 325412.
Novartis Pharmaceuticals Corporation is the only contractor capable of providing PLUVICTO. Novartis Pharmaceuticals Corporation is the sole Food & Drug Administration (FDA) approved source of this highly specialized therapeutic radiopharmaceutical, PLUVICTO (Lutetium Lu-177 Vipivotide Tetraxetan)
This notice of intent is not a solicitation nor is it a request for proposal. However, interested parties that believe they can satisfy the requirement must clearly identify their capability to do so in writing by Monday, July 28, 2025, at 12 pm EST time. Response should be sent to Jerry Choinski at Jerry.Choinski@va.gov. Information submitted in response to this notice will be used solely to determine whether competitive procedures could be used for this acquisition. A determination not to open this requirement to competition based upon responses to this notice is solely within the discretion of the Government.
Files
| File | Type | Posted |
|---|---|---|
| 36C24125Q0671.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside | |
| Sir - Sphere | Veterans Integrated Service Network 16 | No set-aside | |
| 6505--Sources Sought Notice - Ga68 Dotatate (NETSPOT) | Veterans Integrated Service Network 17 | No set-aside | |
| J065--FY27 (BASE 4) RaySearch America RayStation Treatment Planning System Service Contract | Veterans Integrated Service Network 2 | No set-aside | |
| J066--Azenta NitroStore System PM and Support Services | Veterans Integrated Service Network 4 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity